Mediwound Ltd (MDWD NASDAQ) stock market data APIs
$17.6317
-0.16(-0.9%)
as of February 6, 2026
Try our APIs with
free plan!
Mediwound Ltd Financial Data Overview
Price chart is built with
Anychart
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Prev. Close
17.6317
Open
17.4725
High
17.7742
Low
17.3533
52 wk Range
14.14-22.505
Market Cap
221 M
Shares Outstanding
12 835 K
Revenue
20 932 K
EPS
-0.24
Beta
0.128
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Mediwound Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Mediwound Ltd data using free add-ons & libraries
Get Mediwound Ltd Fundamental Data
Mediwound Ltd Fundamental data includes:
- Net Revenue: 20 932 K
- EBITDA: -22 664 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-20
- EPS/Forecast: -0.8133
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Mediwound Ltd News
New
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
MediWound Ltd. MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference Interim assessment and enrollment completion for the EscharEx® VALUE Phase II...
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid® Facility; Full Operational Capacity Expected by Year-End 2025 ...
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: * Walmart (WMT [https://seekingalpha.com/symbol/WMT]) * ZIM Integrated Shipping Services Ltd. (ZIM [https://seekingalpha.com/symbol/ZI...
Nektar Therapeutics (NKTR) Reports Q3 Loss, Beats Revenue Estimates
Nektar Therapeutics (NKTR) came out with a quarterly loss of $1.85 per share versus the Zacks Consensus Estimate of a loss of $2.85. This compares to a loss of $2.7 per share a year ago. These figures...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
